Tag: COVID

  • Chubb’s COVID-19 Claim Denials Draw Litigation from Hollywood

    Chubb’s COVID-19 Claim Denials Draw Litigation from Hollywood

    By Tom Hagy

    Editor and Managing Director
    HB Litigation Conferences
    Editor@LitigationConferences.com

    Chubb’s COVID-19 Claim Denials Draw Litigation from Hollywood

    Well-known policyholder and insurance recovery attorney Kirk Pasich and his firm have sued Chubb insurance companies on behalf of policyholders in the entertainment industry to recover millions in losses they suffered as a result of the Covid-19 pandemic.

    Entertainment Business Interruption

    On Nov. 11, 2020, the firm filed suit on behalf of United Talent Agency LLC in Los Angeles County Superior Court against Vigilant Insurance Co. and Federal Insurance Co. UTA seeks coverage for the millions it lost when concerts and television and movie projections had to be cancelled. The complaint says both carriers are part of the Chubb group, “which has adopted a universal practice of denying coverage for all business interruption claims associated with SARS-CoV-2, Covid-19, and subsequent events” (UTA v. Vigilant, No. 20STCV43745, Calif. Super. Ct., Los Angeles). Acts affected include Post Malone, Guns N’ Roses, and Toby Keith.

    The case hinges in part on the carriers’ assertion that there was no “physical loss or damage.” UTA finds Vigilant based its finding on little information, and knowing for decades that “many courts have held that the presence of a hazardous substance on a property, including the airspace inside buildings, constitutes property damage and that there may be ‘direct physical loss’ to property even if the property is not structurally damaged.”

    Pasich and his partner Michael S. Gehrt represent UTA.

    Film Coverage “Fraudulently Reformed”

    On Sept. 9, 2020, motion picture production company Hoosegow (Hypnotic) Productions Inc. sued Chubb National Insurance Company in federal court in California, arguing that the carrier breached its agreement to extend coverage for the film, titled Hypnotic starring actors including Ben Afleck, should production be delayed.

    When Covid-19 hit and stopped production, Chubb, instead of extending the policy, cancelled it and offered to renew it with a Covid-19 exclusion. This is a “material reduction in the scope of the insurance,” the complaint states (Hoosegow v. Chubb National, No. 2:20-cv-08253, C.D. Calif.).

    “Chubb National’s conduct is despicable,” the complaint continues, “and has been done with a conscious disregard of Hoosegow’s rights, constituting oppression, fraud, and/or malice.” The production company claims substantial financial losses due to the carrier’s “intent to injure,” justifying an award of punitive damages. Breach of contract, bad faith, fraudulent promise without intent to perform, fraud in the inducement, negligent misrepresentation, and fraudulent reformation of the contract are among the claims brought against the carrier.

    Pasich and his colleague Jacquelyn M. Mohr represent Hoosegow.

    Chubb CEO Evan Greenberg reportedly said on an earnings call this summer that plaintiff attorneys are “attempting to torture or reverse engineer insurance contract language to conjure up business interruption coverage that for the most part simply doesn’t exist.”

    Responses, news and articles are welcome. Write to Editor@LitigationConferences.com. 

    Safeguarding Against Financial Exploitation

    An on-demand CLE-eligible webinar Safeguarding Against Financial Exploitation   America’s senior population is growing. Nearly one in five U.S. residents will be 65 or older in 2030. Which means the average age of U.S. investors is climbing too. With that comes the risk that they will be exploited by people with access – or gain access through nefarious methods – to their investment portfolio. Seniors and vulnerable persons lose billions of dollars each year. Remarkably, 90% of the people to take advantage of senior investors are members of their own family. Attorneys who represent senior clients need to know the signs of vulnerability, red flags that their clients are being exploited, what laws apply, and rules lawyers must follow in these matters.   Questions our speakers answer: What is senior / vulnerable investor exploitation?   Who is protected by state and federal laws?   How prevalent is senior financial exploitation? What do the numbers tell us?  What is the pace of financial abuse SAR filings by securities firms?  What are the most popular scams?   What is diminished capacity?  What are the red flags indicating possible exploitation?  What are the laws, rules, and regulations governing law firms?  What are some best practices for law firms?  How can firms best protect their senior clients?   On Demand CLE Webinar What You Get PowerPoint and supplemental materials. Complete recording for later review. Answers to your questions via email. Invitation to contact speakers. 1.5 CLE credits (for licensed attorneys). CLE assistance.* *Subject to state bar rules. For licensed attorneys.  Register Meet the Speakers Joseph Calabrese Bressler, Amery & Ross, P.C. A 1991 Graduate of St. John’s University Law School, Mr. Calabrese brings 30 years of practice and 18 years of Securities Litigation/Regulatory experience to his role as principal in the New York office of  Bressler, Amery & Ross’s Financial Institutions Group. He began his career as a Wall Street litigator as an associate general counsel for Citigroup’s Smith Barney and […]

    Lien Resolution: Government & Private Plans Get Aggressive (Against Attorneys)

    Includes Nearly 75 minutes of insights from experienced professionals. CLE credit: 1+ (subject to bar rules). For CLE questions: CLE@LitigationConference.com The complete Power Point presentation. Continued access to the complete recording for later use. Answers to your questions via email to the presenters or write to HB and we will be sure to contact the speakers. What can you do to settle personal injury suits cleanly and avoid costly litigation and penalties? What recent cases can inform you about protecting your settlements and, as attorneys, yourselves, from post-settlement federal lawsuits? How can your firm set itself up to meet government expectations? What role might experts play in navigating these pitfalls? Medicare Advantage (42 USC § 1395w-22) Federal Medical Care Recovery Act (FMCRA) (42 USC § 2651) Armed Forces Act (10 USC §1095) Veterans’ Benefits (38 USC §1729) Third-Party Collection Rules (32 CFR 537.24; 38 CFR 17.101, etc.) Set-Asides under the Medicare Secondary Payer Act (42 USC § 1395y(b)(2)] On Demand Registration Lien Resolution Government & Private Plans Get Aggressive (Against Attorneys!) On Demand | Recorded September 2020 It is increasingly common these days. Personal injury attorneys settle a case, only to find themselves sued by a U.S. Attorney for failing to reimburse Medicare for conditional payments as required by the Medicare Secondary Payer Act. In some cases the attorney may be required to pay fines in addition to the reimbursements and interest, a costly proposition. Are you up to speed on issues surrounding Medicare Advantage, TRICARE, veterans’ claims, and Medicare set-asides? Join nationally recognized healthcare lien and resolution expert Franklin P. Solomon and go-to lien resolution provider Brett Newman as they offer a practical, in-depth CLE presentation. Franklin P. Solomon, Esq. Attorney & Founder, Solomon Law Firm  A graduate of Rutgers University School of Law at Camden, Franklin Solomon is based in Cherry Hill, NJ, with a practice focused on evaluation, litigation and resolution of healthcare “liens” and reimbursement claims. Mr. Solomon represents personal injury victims and their attorneys […]

    Telepsychiatry: Mitigating the Risks

    REGISTER Registration Includes Nearly 90 minutes of insights from experienced professionals. CLE credit: 1+ (subject to bar rules). For CLE questions: CLE@LitigationConference.com The complete Power Point presentation. Continued access to the complete recording for later use. Answers to your questions via email to the presenters or write to HB and we will be sure to contact the speakers. Understand the risks associated with telepsychiatry and how to manage them.  Telemedicine has emerged as an important solution for healthcare in general and psychiatric medicine specifically during the current global pandemic. Remote access for sub-practices including addiction counseling have been commonly used. Our panel of psychiatric professionals who have served as expert witnesses and attorneys who counsel and represent physicians have prepared a 90-minute session to share insights with attorneys, physicians, healthcare providers, risk professionals, and more. Agenda Examining procedures and best practices that exist for ensuring confidentiality in a telemedicine practice How do you draft a telepsychiatric consent form? What is the emerging standard of care for telemedicine? Will the standard of care for telemedicine become a national standard? (Should it?) Review the case law addressing telemedicine or telepsychiatry How do the HIPAA regulations and HITECH privacy laws impact telemedicine? How have the HIPAA regulations and HITECH privacy laws been relaxed during the pandemic? Will the relaxed HIPAA and HITECH regulations impacting telemedicine continue past the pandemic? Which technical platforms are preferred? Which ones to avoid? Panelists Mark Levy, M.D., Medical Director at fpamed David Kan, M.D., UCSF Psychiatry Department and the California Society for Substance Abuse Medicine Ayesha Ashai, M.D., associated with fpamed Stephen M. Fatum, J.D., Partner, Barnes & Thornburg LLP Angela W. Russell, J.D., Partner, Wilson Elser Moskowitz Edelman & Dicker LLP Meet our physician and attorney panelists. Mark Levy MD Medical Director fpamed Dr. Levy is a graduate of Columbia College (A.B. 1967) and the Columbia University College of Physicians and Surgeons (M.D. 1971) in New York. He is a Physician […]

    The Commercial Drone Industry: Privacy, Security, Threats, and Mitigation of Risk

    HB presents a CLE-eligible webinar Now on-demand at the West LegalEdcenter THE COMMERCIAL DRONE INDUSTRY Privacy, Security, Threats, and Mitigation of Risk Drones have become an increasingly valuable tool for businesses of all types and sizes. Drones are already being used in many applications, but more will certainly arise as the technology advances. This means that certain risks, like cyber threats, will also continue to present themselves. Protecting the transmission and storage of data collected through drones is critical. Unfortunately, security usually comes as an afterthought. The drone industry is part of the aviation industry, which, based on its knowledge, keeps safety as a number one concern. Part of that safety is having proper protection for your systems, including security as a fundamental design principle. Take this webinar to gain insights on the topics listed below, and shared by an attorney who practices on the cutting-edge of this evolving technology. Topics: Defining drones. Current and future applications. FAA Modernization and Reform Act of 2012. FAA Part 107 Regulations and waivers. Resources, e.g. the FAA Drone Zone and LAANC Portal. Penalties for violations. Privacy implications. Drones as weapons. Vulnerability to cyber attacks. Take it now! What you get: 1+ CLE credits (subject to bar rules). Insights from an experienced professional who specializes in this area of the law. The complete PowerPoint presentation. Continued access to the complete recording for later use. Answers to your questions. Fee: No additional charge to subscribers to the West LegalEdcenter. Non-subscribers may take the course for $170. Meet the Speaker Kathryn Rattigan Robinson & Cole LLP Kathryn Rattigan is a member of the firm’s Business Litigation Group and Data Privacy + Cybersecurity Team. She advises clients on data privacy and security, cybersecurity, and compliance with related state and federal laws. She assists clients in assessing risks related to technology and software contracts, as well as with compliance-related issues with outsourcing and […]

    The Intersection of Privacy and Antitrust Webinar Now Available On-Demand on the West LegalEdcenter

    Available as part of your subscription to The Thomson Reuters West LegalEdcenter®. Don’t subscribe to the West LegalEdcenter? This webinar is still available directly from HB. Take it now! Questions for speakers Questions@LitigationConferences.com CLE questions CLE@LitigationConferences.com Check out the MoginRubin blog for more insights on antitrust and privacy law. What attorneys and companies need to know about the increasing interplay between these critical areas of the law.  Highly publicized cases and investigations in the U.S. and Europe of big technology, e-commerce, and social media companies demonstrate how anti-competition laws are being used to scrutinize and challenge not only how these corporations conduct themselves in the marketplace, but the very core of their colossal success: the mass collection and utilization of user data. Are the privacy and antitrust worlds beginning to cross over? Or do they simply run parallel while addressing entirely different types of conduct? Whatever the answer, data is the raw material that drives the likes of Google, Facebook, Apple and Amazon, so how it is handled is a critical question when counseling clients on mergers and acquisitions. Moderator Daniel J.  Mogin | Managing Partner, MoginRubin LLP Speakers Jennifer M. Oliver, CIPP/US | Partner, MoginRubin LLP Thomas N. Dahdouh | Director, Western Region, Federal Trade Commission Franklin M. Rubinstein | Partner, Wilson Sonsini Goodrich & Rosati Randi W. Singer, CIPP/US, CIPT | Partner, Weil, Gotshal & Manges Contributor Dina Srinivasan | Independent Researcher & Author of The Antitrust Case Against Facebook Dina was unable to present but we thank her for her content contributions.  Agenda Who should regulate privacy violations in the U.S.? Which antitrust issues implicate privacy concerns? What role does machine learning play on the competitive landscape? What is big data really? How is it different from “data”? What are the elements of effective merger reviews? What are the appropriate remedies? What are “notice-and-choice” versus “harms-based” approaches? Plus answers to your questions. Send them to Questions@LitigationConferences.com.

  • Organizational Values & Business Risks: Properly Balancing Stakeholder Concerns

    Organizational Values & Business Risks: Properly Balancing Stakeholder Concerns

    Topics Covered

    Accommodations. Appropriate accommodation for high-risk employees or employees with family members who are at a heightened risk.

    Mitigation. Attention to means of mitigating transmission and infection.

    Tracing. Contact tracing and management of data collected, including health data, as well as responses to employees who refuse to report.

    Patient Sensitivity. Duty to avoid discrimination and stigmatization.

    Preparedness. Developing plans to address possibility of re-occurrence in the fall and managing possible outbreaks in company’s offices.

    Take it now

    On-demand on the Thomson Reuters West LegalEdcenter as part of the HB catalog.

    Register now!

    Organizational Values & Coronavirus Business Risks:
    Properly Balancing Stakeholder Concerns

    Produced for Emory University Center for Ethics by HB Litigation Conferences

    The current pandemic confronts businesses, nonprofit organizations, governments, and the legal profession with innumerable ethical challenges.  Management issues and liability concerns, stakeholder demands and legal duties become even more complex in an environment of uncertainty and one where the consequences could result in serious illness or even death.  This program seeks to engage the participants in thinking through these challenges and developing processes of ethical response to them.  Managers must acknowledge and address the framework of fear associated with the pandemic, ranging from fear of contagion and death to fears of unemployment, childcare, and the duties of home-schooling.  Additionally, as the economy reopens there must be serious attention to the processes of doing so.

    Join Professor Edward L. Queen from Emory University for invaluable insights. Emory’s medical team was on the frontline of the 2014-2016 Ebola epidemic, which began in December 2013 when an 18-month-old Guinean boy contracted the disease. According to the CDC, the outbreak ended with more than 28,600 cases and 11,325 deaths. Eleven people were treated for Ebola in the United States.

    Edward L. Queen
    Director of Ethics and Servant Leadership
    Emory University

    Professor Queen Coronavirus-Ethical-Issues-Litigation Conferences-June-19-2020-

    Professor Edward L. Queen

    Edward L. Queen is director of the D. Abbott Turner Program in Ethics and Servant Leadership and Coordinator of Undergraduate Studies at Emory University’s Center for Ethics.  At Emory he also serves as Director of Research for the Institute of Human Rights and co-convener of the Initiative on Religion, Conflict, and Peacebuilding.  Queen received his B.A. from Birmingham-Southern College, his M.A. and Ph.D. degrees from the Divinity School of the University of Chicago, and his J.D. from the Indiana University School of Law-Indianapolis. Queen’s previously served as founding director of the Religion and Philanthropy Project at the Indiana University Center on Philanthropy and of the Islamic Society of North America’s Fellowship Program in Nonprofit Management and Governance.  A former program officer at Lilly Endowment, Inc. with a major responsibility for grants in nonprofit governance and leadership, Queen has consulted with numerous nonprofit, governmental, and educational organizations on management issues and ethics policies.  These organizations have included the Helsinki Committee for Human Rights, the Pew Charitable Trusts, Independent Sector, USAID, NAFSA: The Association of International Educators, the Southeastern Council of Foundations, and the Corporation for National and Community Service.

    A specialist in issues related to professional and social ethics, religious and ethnic conflict, and civil society, Queen has written, coauthored, or edited numerous books, including Serving Those In Need: A Handbook for Managing Faith-Based Human Services Organizations (2000), Philanthropy in the World’s Traditions (1998), and The Encyclopedia of American Religious History (1992, rev. ed. 2002, 3rd rev. ed. 2009).

  • Healthcare Industry Antitrust Measures Advance as Pandemic Pressures Persist

    Healthcare Industry Antitrust Measures Advance as Pandemic Pressures Persist

    Healthcare Industry Antitrust Measures Advance as Pandemic Pressures Persist

    Did consolidation help frustrate U.S. COVID-19 preparedness?

    Clearly antitrust enforcers must consider external circumstances like the COVID-19 crisis when making enforcement decisions, and the agencies have bene able to pivot to respond to this crisis remarkably quickly. It is important, however, to also consider whether and how these emergency COVID-19 collaborations will unwind once the crisis has subsided. Collaborating competitors will have already shared critical information and resources, and that momentum can be difficult to halt.

    Jennifer M. Oliver, Partner, MoginRubin LLP

    READ MORE

    Jennifer M. Oliver
    Partner
    MoginRubin LLP

  • Cannabis, CBD: Advertising and Drug Test Problems

    Cannabis, CBD: Advertising and Drug Test Problems

    COVID-19 vs Cannabis: Are Closures Legal?

    In the category of “damned if you do; damned if you don’t,” Massachusetts Governor Charlie Baker shut down recreational cannabis shops, citing concerns over the spread of COVID-19. The dispensaries say the shutdown could seriously damage the industry. But, the governor said, the spread of disease will continue to damage the health of his constituents, especially as residents of states where recreational marijuana is illegal, come to Massachusetts to do their cannabis shopping. Citizens of the state may still obtain medical cannabis, as reported by WBUR.

    Too Much TCH: Can CBD Use Cost You Your Job?

    A New York truck driver has sued a CBD company for allegedly making a product, which he says he uses for pain relief, with too much THC, more than the label indicates. A Pennsylvania woman filed a similar case and a Missouri school bus monitor had a similar experience. Another Missourian blames the store where he purchased his CBD, saying he was assured the product contained minimal THC. All claim they were told they could pass drug tests. All failed their test. And all lost their jobs, according to a post on the Huffs & Puffs website.

    “Courtesy of a dearth of strict standards of testing, many companies tend to list lower values of THC on the product label,” writes Huffs & Puffs. “The quantities of THC will never be ‘as high to make you high’ but they may be enough for you to fail a drug test, conducted via not the most of the sophisticated equipment out there.”

    “For entrepreneurs in the cannabis niche, this is a topic of huge concern as the number of such lawsuits are only going to increase as people keep failing drug tests after consuming CBD.

    Not Enough THC: No Golden Ticket

    Californians have proposed a class action against the owners of a CBD-infused-chocolate factory for selling candy with far less CBD and THC than advertised. For consumers these ingredients justified the premium prices they were paying. And yet, as shareholders, executive officers and managers allegedly knew, the levels were below what the labels had them believe, says Law360.

    No Proof of Health Claims

    The FTC has sued Whole Leaf Organics over the company’s claims that their CBD products effectively treat cancer and prevent or reduce COVID-19 risk. The Bureau of Consumer Protection says that there is “no proof that any product will prevent or treat COVID-19 or that any CBD product will treat cancer.” We can only hope.

    The California marketer and founder of Whole Leaf, Marc Ching, agreed to a preliminary order that prohibits him from making those claims. Pending the resolution of a parallel FTC administrative action, the proposed order also bars the defendant from representing that three CBD-based products he sells are effective cancer treatments.

    According to the FTC: Since December 2018, defendant Marc Ching, also doing business as Whole Leaf Organics, has sold Thrive – a tablet consisting primarily of Vitamin C and herbal extracts. But beginning in March 2020, Thrive underwent something of a marketing make-over. The defendant began pitching the product as a way for consumers to ward off coronavirus. His website claimed, “Formulated with potent antiviral herbal extracts, Thrive by Whole Leaf Organics is the perfect way to strengthen your immunity against pathogens like ‘COVID-19,’ the coronavirus.” The defendant also represented that the product is indicated to “combat” a list of ailments, “as well as the coronavirus.” In addition, the defendant claimed Thrive is “formulated with clinically tested and proven ingredients” and that “our time test formulas are proven and deliver results.”

    Photo by Matthew Brodeur on Unsplash

  • Organizational Values & Coronavirus Business Risks | Join Our Webinar June 18

    Organizational Values & Coronavirus Business Risks | Join Our Webinar June 18

    Webinar:
    June 18, 2020
    2:00 pm ET
    60 mins.
    CLE: 1+
    Complimentary with registration.

    Get:
    +CLE
    +Materials
    +Recording
    +Answers!

    Also available to subscribers of the West LegalEdcenter.
    Register there!

    Email us your:
    Speaker questions
    CLE questions

    Speaker:

    Professor Edward L. Queen Ph.D. , J.D.
    Director Ethics and Servant Leadership: Emory Center for Ethics
    Emory University

    Organizational Values & Coronavirus Business Risks
    Properly Balancing Stakeholder Concerns

    Thursday, June 18, 2020 | 2pm ET | 1pm CT | 12pm MT | 11am PT 

    The pandemic brings with it complex liability concerns, stakeholder demands and legal duties.  We will take a closer look. 

    The current pandemic confronts businesses, nonprofit organizations, governments, and the legal profession with innumerable ethical challenges.  Management issues and liability concerns, stakeholder demands and legal duties become even more complex in an environment of uncertainty and one where the consequences could result in serious illness or even death.  This program seeks to engage the participants in thinking through these challenges and developing processes of ethical response to them.  Managers must acknowledge and address the framework of fear associated with the pandemic, ranging from fear of contagion and death to fears of unemployment, child care, and the duties of home-schooling.  Additionally, as the economy reopens there must be serious attention to the processes of doing so, including:

    We will address:   

    • Appropriate accommodation for high-risk employees or employees with family members who are at a heightened risk;

    • Attention to means of mitigating transmission and infection;

    • Contact tracing and management of data collected, including health data, as well as responses to employees who refuse to report;

    • Duty to avoid discrimination and stigmatization;

    • Developing plans to address possibility of re-occurrence in the fall and managing possible outbreaks in company’s offices.